Infantile spasms are a rare but severe form of epilepsy affecting babies, typically between three and twelve months of age. These seizures look like brief jerking or stiffening movements and often occur in clusters. Quick recognition and treatment are critical because delayed care can seriously affect a baby’s developing brain and lead to lifelong challenges with learning, movement, and other abilities. Understanding the available treatments—both standard medications and approaches being tested in research—can help families and doctors work together to give affected infants the best possible chance for healthy development.

Why Treating Infantile Spasms Quickly Matters

When a baby develops infantile spasms, time becomes extremely important. The goal of treatment is not only to stop the seizures but also to protect the developing brain from further harm. These spasms are not just simple movements—they are actually seizures that can rapidly interfere with how a baby’s brain grows and learns. Even a delay of just a few days or weeks without proper treatment can lead to serious problems with thinking, speaking, moving, and interacting with others later in life.^[1][8]

Treatment decisions depend on several factors. Doctors consider the baby’s age, whether there is a known cause for the spasms, and how the baby is developing overall. Some babies may have had normal development before the spasms started, while others may already have shown delays or other medical conditions. Each baby’s situation is unique, and treatment plans are carefully tailored to fit individual needs.^[9]

There are established treatments that medical guidelines recommend, based on years of clinical experience and research. At the same time, scientists are actively studying new therapies in clinical trials. These studies aim to find better ways to control spasms, protect brain development, and improve long-term outcomes for children. Families should know that both proven treatments and investigational options exist, and neurologists work closely with parents to choose the best path forward.^[9]

Standard Medical Treatments for Infantile Spasms

The main treatments that doctors prescribe for infantile spasms have been used for many years and are supported by medical guidelines and clinical studies. These treatments focus on stopping the spasms as quickly as possible to protect the baby’s brain. The two most commonly used first-line options are hormonal therapy and a medication called vigabatrin, which is an anti-seizure medicine.^[8][9]

Hormonal therapy often involves a drug called adrenocorticotropic hormone (ACTH) or high doses of corticosteroids such as prednisolone. ACTH is usually given as an injection into the muscle, while prednisolone is taken by mouth. Both work by affecting the immune system and reducing inflammation in the brain, though scientists do not fully understand all the ways these hormones help stop spasms. Studies have shown that hormonal therapy can be highly effective at stopping spasms in many babies, sometimes within just a few days or weeks.^[7][9]

High-dose prednisolone is often chosen as the first treatment in many countries because it is effective and can be given at home. The treatment typically lasts for several weeks, followed by a gradual reduction in dose over time to avoid sudden withdrawal effects. During this period, doctors closely monitor the baby’s blood pressure, blood sugar, and weight, as these medications can cause side effects. Common side effects include increased appetite, irritability, changes in sleep, high blood pressure, and a higher risk of infections because the immune system is temporarily weakened.^[7][11]

Vigabatrin is another important treatment option. This medication works by increasing the levels of a calming chemical in the brain called GABA (gamma-aminobutyric acid), which helps reduce abnormal electrical activity that causes seizures. Vigabatrin is especially recommended when infantile spasms are caused by a condition called tuberous sclerosis complex, a genetic disorder that can cause tumors to grow in the brain and other organs. For babies with tuberous sclerosis, vigabatrin is often the first choice because it has been shown to work particularly well in these cases.^[7][11]

One important consideration with vigabatrin is that it can sometimes cause vision problems. The medication can lead to permanent changes in the outer edges of the visual field in some patients, meaning they may lose some side vision. Because of this risk, doctors carefully weigh the benefits and risks, and they may arrange regular eye exams during treatment. However, for many babies, especially those with tuberous sclerosis, the benefits of stopping the spasms outweigh the potential risks.^[9]

Some doctors may use a combination of hormonal therapy and vigabatrin together. Research has shown that combining these treatments can lead to a higher rate of spasm control compared to using either treatment alone. However, combination therapy does not appear to improve developmental outcomes at 18 months compared to using prednisolone by itself. This means that while the spasms may stop more quickly, the long-term effects on learning and development are similar either way.^[11]

If the first treatment does not work, doctors may try other anti-seizure medications. These can include drugs like valproate, topiramate, zonisamide, or levetiracetam. Each of these medications works in a different way to calm the brain’s electrical activity. Unfortunately, infantile spasms are often difficult to control, and not every baby responds to the first medication tried. Finding the right treatment sometimes requires patience and careful monitoring.^[9]

In some cases, doctors may recommend a special diet called the ketogenic diet. This is a high-fat, low-carbohydrate diet that changes the way the body uses energy. The diet has been shown to help reduce seizures in some children with epilepsy, including those with infantile spasms. The diet must be carefully supervised by a dietitian and medical team because it requires precise meal planning and monitoring to ensure the baby gets all necessary nutrients. It can be challenging to follow, but for some families, it offers an additional option when medications are not enough.^[15]

In rare situations, surgery may be considered. If the spasms are caused by a specific problem in one area of the brain—such as a small malformation or scar—removing or disconnecting that area may stop the seizures. Surgery is only an option when doctors can clearly identify the source of the seizures and when the benefits of surgery outweigh the risks. A procedure called a corpus callosotomy, which involves cutting the connection between the two halves of the brain, has been used in some children to reduce the severity of seizures, though it does not cure epilepsy.^[18]

New Treatments Being Studied in Clinical Trials

Scientists around the world are working hard to find better treatments for infantile spasms. Clinical trials are research studies where new medications, therapies, or treatment approaches are carefully tested to see if they are safe and effective. These studies are essential because they help doctors discover treatments that may work better, have fewer side effects, or help babies who do not respond to current options.^[9]

Clinical trials for infantile spasms typically go through several phases. Phase I trials focus on safety. Researchers give the new treatment to a small number of patients to see if it is safe and to determine the best dose. Phase II trials test whether the treatment actually works to stop spasms or improve brain development. These studies involve more patients and help researchers understand how effective the treatment is. Phase III trials compare the new treatment to the current standard treatments to see if it is better, as good, or has fewer side effects. Only after a treatment passes through all these phases can it be approved for widespread use.^[9]

One area of research focuses on finding new ways to use existing medications or discovering entirely new drugs that target the brain processes involved in infantile spasms. For example, researchers are studying whether adjusting the dose or timing of hormonal therapy can improve outcomes. Other studies are looking at whether combining different medications in new ways can be more effective than current approaches.^[9]

Another promising area of research involves understanding the genetic and molecular causes of infantile spasms. Scientists have discovered that many cases are linked to changes in specific genes. By identifying these genetic changes, researchers hope to develop targeted therapies that address the underlying cause rather than just treating the symptoms. For example, if a baby has infantile spasms due to a specific metabolic disorder, correcting the metabolic problem might stop the seizures and protect brain development.^[6]

Some clinical trials are exploring the use of immunotherapy approaches. Since infantile spasms may involve inflammation or immune system problems in the brain, researchers are testing whether medications that specifically target the immune system can help. These might include newer types of corticosteroids or other immune-modulating drugs that have fewer side effects than current options.^[6]

Researchers are also investigating whether treatments that support brain development and repair can help babies recover more fully. This includes studying medications or therapies that promote the growth of healthy brain connections or protect brain cells from damage. While these approaches are still in early stages of research, they offer hope for improving long-term developmental outcomes, not just stopping the seizures.^[6]

In addition to new medications, some clinical trials are testing the effectiveness of specialized diets, nutritional supplements, or even devices that stimulate the brain in specific ways. One example is the vagus nerve stimulator (VNS), a device implanted under the skin that sends regular electrical signals to the brain to help prevent seizures. While VNS has been used for other types of epilepsy, its role in treating infantile spasms is still being studied.^[18]

Families who are interested in clinical trials should talk with their child’s neurologist. Not every baby will be eligible for every trial, as studies often have specific requirements based on age, type of spasms, previous treatments, and other medical conditions. Trials may be available in specialized epilepsy centers in countries such as the United States, Europe, and other regions. Participating in a clinical trial means that the baby will receive close medical monitoring and may have access to cutting-edge treatments before they become widely available.^[9]

Most Common Treatment Methods

• Hormonal Therapy
  • Adrenocorticotropic hormone (ACTH) given as injections into the muscle to reduce brain inflammation and stop spasms^[9]
  • High-dose prednisolone taken by mouth, often used as first-line treatment in many countries^[7]
  • Treatment typically lasts several weeks followed by gradual dose reduction^[11]
  • Requires close monitoring of blood pressure, blood sugar, and weight during treatment^[11]
  • Side effects may include increased appetite, irritability, high blood pressure, and higher risk of infections^[7]
• Anti-Seizure Medications
  • Vigabatrin increases calming brain chemicals (GABA) to reduce abnormal electrical activity^[9]
  • First-line treatment for infantile spasms caused by tuberous sclerosis complex^[11]
  • May cause permanent changes in side vision in some patients, requiring regular eye monitoring^[9]
  • Other medications like valproate, topiramate, zonisamide, or levetiracetam may be used if first treatments fail^[9]
  • Combination of prednisolone and vigabatrin may increase spasm control rates^[11]
• Dietary Therapy
  • Ketogenic diet uses high fat and low carbohydrate intake to change how the body uses energy^[15]
  • Can help reduce seizures in some children when medications are not sufficient^[15]
  • Requires careful supervision by a dietitian and medical team with precise meal planning^[15]
• Surgical Options
  • Brain surgery to remove or disconnect abnormal brain areas causing seizures in select cases^[15]
  • Corpus callosotomy involves cutting connections between brain halves to reduce seizure severity^[18]
  • Only considered when seizure source is clearly identified and benefits outweigh risks^[15]
• Device-Based Therapy
  • Vagus nerve stimulator (VNS) implanted device sends electrical signals to brain to help prevent seizures^[18]
  • Role in treating infantile spasms still being studied in clinical research^[18]